Dialogue Health Technologies Inc.
Dialogue Health Technologies Inc. (DLHTF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dlhtf · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Dialogue Health Technologies Inc. (DLHTF) measures how much investors pay for each dollar of the company's trailing earnings. DLHTF's current PE ratio of N/A is calculated by dividing its stock price of $3.79 by its TTM earnings per share of -$0.37.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2018 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Dialogue Health Technologies Inc.You DLHTF | $255M | N/A | — | -$0.37 |
 biote Corp. BTMD | $103M | 3.01x | -83.1% | $0.86 |
 NIOX Group Plc CSSPF | $274M | 40.40x | +127.5% | $0.02 |
 Faron Pharmaceuticals Oy FPHAF | $210M | N/A | — | -$0.00 |
 Guerbet S.A. GUERF | $281M | 16.84x | -5.2% | $1.28 |
 Hamilton Thorne Ltd. HTLZF | $245M | N/A | — | -$0.00 |
 Newron Pharmaceuticals S.p.A. NWPHF | $416M | 10.81x | -39.2% | $0.85 |
Industry Average 4 peers with valid PE | — | 17.76x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-0.39 | — | |
2021-12-31 FY2021 | — | $-4.48 | — | |
2020-12-31 FY2020 | — | $-0.31 | — | |
2019-12-31 FY2019 | — | $-0.19 | — | |
2018-12-31 FY2018 | — | $-0.16 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Dialogue Health Technologies Inc. (DLHTF) measures how much investors pay for each dollar of the company's trailing earnings. DLHTF's current PE ratio of N/A is calculated by dividing its stock price of $3.79 by its TTM earnings per share of -$0.37.
Frequently asked questions
DLHTF pe ratio · 6 questionsDLHTF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.79 and TTM EPS of -$0.37. Data sourced from Financial Modeling Prep via DLHTF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Dialogue Health Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09